Evidence map›Paper›PMID 40070966›Full record

ArticleFrontiers in microbiology2024

A mass spectrometry-based strategy for investigating volatile molecular interactions in microbial consortia: unveiling a

Antonio Azzollini, Barbara Sgorbini, Nicole Lecoultre, Carlo Bicchi, Jean-Luc Wolfender, Patrizia Rubiolo, Katia Gindro

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Exploring the antifungal activity of the wheat microbiome.Biochemical Society transactions · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Antonio Azzollini *School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
Barbara Sgorbini *Department of Drug Science and Technology, University of Turin, Turin, Italy.
Nicole LecoultreAgroscope, Mycology Group, Nyon, Switzerland.
Carlo BicchiDepartment of Drug Science and Technology, University of Turin, Turin, Italy.
Jean-Luc WolfenderSchool of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
Patrizia RubioloDepartment of Drug Science and Technology, University of Turin, Turin, Italy.
Katia GindroAgroscope, Mycology Group, Nyon, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Co-cultivation of microorganisms has emerged as a promising methodology for deciphering the intricate molecular interactions between species. This approach facilitates the replication of natural niches of ecological or clinical relevance where microbes consistently interact. In this context, increasing attention has been addressed toward elucidating the molecular crosstalk within fungal co-cultures. However, a major challenge in this area of research is determining the fungal origin of metabolites induced in co-cultivation systems. Molecules elicited in co-cultures may not be detectable in the individual cultures, making it challenging to establish which microorganism is responsible for their induction. For agar-diffused metabolites, imaging mass spectrometry can help overcome this obstacle by localizing the induced molecules during fungal confrontations. For volatile metabolites, however, this remains an open problem. To address this issue, in this study, a three-head-to-head co-culture strategy was developed, specifically focusing on the exploration of volatile interactions between fungi via headspace solid-phase microextraction combined with gas chromatography mass spectrometry. This methodology was applied to study the volatile molecular interactions of three fungal species:

Indexed as

antifungalAspergillusCladosporiumco-cultureFusariummass spectrometryVOC-mediated interactionsvolatile molecules

Identifiers

PMID40070966
PMCPMC11895703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.